Anyone who is 18 years or older (16 or older for acne and birth control prescriptions), and is located in Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Prince Edward Island, Saskatchewan or Ontario
By month three, most people on therapeutic doses have lost 5 to 10 percent of their starting body weight
The Regulatory Landscape: SFDA Standards and RUO Compliance The Saudi Food and Drug Authority (SFDA) and the Ministry of Health strictly regulate the importation and distribution of research compounds
nejm.org/doi/full/10.10 #MedTwitter #GLP1 #Endocrinology #ObesityMedicine GLP-1 receptor agonists are doing more than glucose control, with effects across appetite, heart, kidney, and metabolism
Severe low testosterone symptoms may necessitate starting with TRT, while significant weight loss goals might prioritize a GLP-1 like semaglutide. One of the biggest concerns when starting two medications at the same time is that if a side effect occurs, it can be difficult to know which one caused it, says Staheli
Semaglutide has a longer safety record and FDA approval for weight loss